| ET to discuss these results | The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements |
|---|---|
| , June 03, 2021 GLOBE NEWSWIRE -- Motus GI Holdings, Inc | Food and Drug Administration FDA for one of its medical devices |
com and connect with the Company on Twitter, LinkedIn and Facebook.
| Forward-looking statements are based on the Company's current expectations and assumptions | To access the conference call, investors are invited to dial 877 407-0792 U |
|---|---|
| Motus GI believes the Pure-Vu System may lead to positive outcomes and lower costs for hospitals by safely and quickly improving visualization of the colon and upper GI tract, enabling effective diagnosis and treatment the first time | About the Pure-Vu System The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper gastrointestinal GI procedures while preserving established procedural workflow and techniques |
Food and Drug Administration FDA issued 510 k clearance for the Pure-Vu GEN2 System.